Literature DB >> 11155443

Chemokines and their receptors in infectious disease.

D H McDermott1, P M Murphy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11155443     DOI： 10.1007/s002810000052

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  120 in total

1.  Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.

Authors:  P A Zimmerman; A Buckler-White; G Alkhatib; T Spalding; J Kubofcik; C Combadiere; D Weissman; O Cohen; A Rubbert; G Lam; M Vaccarezza; P E Kennedy; V Kumaraswami; J V Giorgi; R Detels; J Hunter; M Chopek; E A Berger; A S Fauci; T B Nutman; P M Murphy
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion.

Authors:  P Steinberger; J Andris-Widhopf; B Bühler; B E Torbett; C F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

Authors:  R Liu; W A Paxton; S Choe; D Ceradini; S R Martin; R Horuk; M E MacDonald; H Stuhlmann; R A Koup; N R Landau
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 4.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

Authors:  E A Berger; P M Murphy; J M Farber
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

5.  Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis.

Authors:  A S Lalani; J Masters; K Graham; L Liu; A Lucas; G McFadden
Journal:  Virology       Date:  1999-04-10       Impact factor: 3.616

6.  Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus.

Authors:  E Palacios; L Digilio; H M McClure; Z Chen; P A Marx; M A Goldsmith; R M Grant
Journal:  Curr Biol       Date:  1998 Jul 30-Aug 13       Impact factor: 10.834

7.  CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.

Authors:  D Schols; P Proost; S Struyf; A Wuyts; I De Meester; S Scharpé; J Van Damme; E De Clercq
Journal:  Antiviral Res       Date:  1998-10       Impact factor: 5.970

8.  Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.

Authors:  K Mossman; P Nation; J Macen; M Garbutt; A Lucas; G McFadden
Journal:  Virology       Date:  1996-01-01       Impact factor: 3.616

9.  Long-term impaired neutrophil migration in mice overexpressing human interleukin-8.

Authors:  W S Simonet; T M Hughes; H Q Nguyen; L D Trebasky; D M Danilenko; E S Medlock
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages.

Authors:  S Swingler; A Mann; J Jacqué; B Brichacek; V G Sasseville; K Williams; A A Lackner; E N Janoff; R Wang; D Fisher; M Stevenson
Journal:  Nat Med       Date:  1999-09       Impact factor: 87.241
View more
  3 in total

1.  Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.

Authors:  David H McDermott; Alan M Fong; Qiong Yang; Joan M Sechler; L Adrienne Cupples; Maya N Merrell; Peter W F Wilson; Ralph B D'Agostino; Christopher J O'Donnell; Dhavalkumar D Patel; Philip M Murphy
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.

Authors:  David H McDermott; Susan E Conway; Tao Wang; Stacy M Ricklefs; Manza A Agovi; Stephen F Porcella; Huong Thi Bich Tran; Edgar Milford; Stephen Spellman; Reza Abdi
Journal:  Blood       Date:  2010-01-12       Impact factor: 22.113

Review 3.  Bench-to-bedside review: Platelets and active immune functions - new clues for immunopathology?

Authors:  Olivier Garraud; Hind Hamzeh-Cognasse; Bruno Pozzetto; Jean-Marc Cavaillon; Fabrice Cognasse
Journal:  Crit Care       Date:  2013-08-27       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.